MCM
HCAT icon

Manchester Capital Management’s Health Catalyst HCAT Stock Holding History

Manchester Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,890
Closed -$13.9K – 1406
2025
Q3 		$13.9K Hold
4,890
– – ﹤0.01% 812
2025
Q2 		$18.4K Buy
4,890
+1,241
+34% +$4.88K ﹤0.01% 726
2025
Q1 		$16.5K Hold
3,649
– – ﹤0.01% 748
2024
Q4 		$25.8K Hold
3,649
– – ﹤0.01% 668
2024
Q3 		$29.7K Hold
3,649
– – ﹤0.01% 642
2024
Q2 		$23.3K Buy
3,649
+1,621
+80% +$10.4K ﹤0.01% 639
2024
Q1 		$15.3K Hold
2,028
– – ﹤0.01% 587
2023
Q4 		$18.8K Sell
2,028
-217
-10% -$1.77K ﹤0.01% 546
2023
Q3 		$22.7K Hold
2,245
– – ﹤0.01% 512
2023
Q2 		$28.1K Hold
2,245
– – ﹤0.01% 463
2023
Q1 		$26.2K Buy
2,245
+748
+50% +$9.54K ﹤0.01% 479
2022
Q4 		$15.9K Buy
1,497
+28
+2% +$270 ﹤0.01% 431
2022
Q3 		$14K Buy
1,469
+45
+3% +$596 ﹤0.01% 430
2022
Q2 		$21K Buy
1,424
+265
+23% +$4.52K ﹤0.01% 410
2022
Q1 		$30K Buy
1,159
+1,008
+668% +$28.6K ﹤0.01% 432
2021
Q4 		$6K Buy
151
+8
+6% +$365 ﹤0.01% 635
2021
Q3 		$7K Buy
+143
New +$7.8K ﹤0.01% 630

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manchester Capital Management's HCAT Position: Q4 2025 in Review

Manchester Capital Management sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 4,890 shares — an estimated $13.9K sold.

Manchester Capital Management first reported a position in HCAT in Q3 2021 and held it in 17 quarters. The position peaked at $30K in Q1 2022. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Manchester Capital Management reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Manchester Capital Management sold 4,890 Health Catalyst shares in Q4 2025, an estimated $13.9K.
  • Manchester Capital Management first reported a position in Health Catalyst in Q3 2021 and held it in 17 quarters.
  • Manchester Capital Management's Health Catalyst position peaked at $30K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Manchester Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.